Fras JP, Guja C, Hardy E, et al
As of December 2024, the FDA approved tirzepatide for treatment of moderate-to-severe obstructive sleep apnea (OSA) in patients with obesity based on the results of two trials
However, current data concerning bariatric surgery effectiveness in genetic and syndromic obesity, specifically in patients with PWS, are generally based on few case reports, and results are not easy to compare due to differences in surgical procedures and duration of follow-up [49]
Sappanone a alleviates osteoarthritis progression by inhibiting chondrocyte ferroptosis via activating the sirt1/nrf2 signaling pathway
Liposomal liquid or pouches offer a high-absorption alternative that you can easily incorporate into your morning at home
Unlike DepB, its homolog from Sphingomonas sp